Assignee
BETAGENON AB
SE·3 granted patents·4 pending applications·3 citations·filing 2001–2024
Top patents by PatentIndex Score
7 records- 0193US11691954B2FormulationsBETAGENON AB·Filed 2022·Granted Jul 4, 2023·2 cites·47 claims
- 0291US12162850B2FormulationsBETAGENON AB·Filed 2023·Granted Dec 10, 2024·1 cites·33 claims
- 0379US2025289791A1FormulationsBETAGENON AB·Filed 2024·Application pending·0 cites
- 0458US2025136563A1Thiadiazolone derivatives useful as ampk activatorBETAGENON AB·Filed 2022·Application pending·0 cites
- 0557US2024082222A14-chloro-n-[2-[(4-chlorophenyl)methyl]-3-oxo-1,2,4-thiadiazol-5-yl]benzamide for use in medicineBETAGENON AB·Filed 2022·Application pending·0 cites
- 0638US2011177046A1Dithiazolidine and thiazolidine derivatives as anticancer agentsBETAGENON AB·Filed 2008·Application pending·0 cites
- 0729US7098375B2Animal and cell models for type II diabetes and their useBETAGENON AB·Filed 2001·Granted Aug 29, 2006·0 cites·4 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →